ACT-DE for Diabetes Distress and HbA1c in Adults With Type 2 Diabetes
ACT-DE
The Effects of Acceptance-based Diabetes Education on Diabetes Distress and Glycaemic Control in Adults With Type 2 Diabetes: A Randomised Controlled Trial.
1 other identifier
interventional
176
1 country
1
Brief Summary
This study will evaluate the effectiveness of a structured acceptance-based diabetes education programme for adults with type 2 diabetes compared with those who received diabetes education. The programme mainly comprises acceptance and commitment therapy (ACT) as a psychological component and a diabetes education (DE) component. The short form of the programme is named 'ACT-DE'. This programme aims to decrease the diabetes distress level in participants with type 2 diabetes and improve their blood glucose level. The objectives are:
- 1.To develop an ACT-based intervention protocol as a guide for promoting healthy coping in people with type 2 diabetes who are psychologically distressed.
- 2.To examine the effects of 'ACT-DE' on diabetes distress and HbA1c (primary outcomes) over a three-month follow-up, when compared with diabetes education only.
- 3.To examine the effects of 'ACT-DE' on diabetes self-management behaviours, self-efficacy in diabetes care, and psychological flexibility (secondary outcomes) over the three-month follow-up, when compared with diabetes education; and
- 4.To identify the relationships between psychological flexibility and diabetes self-efficacy, diabetes self-management behaviour and HbA1c among the study participants
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2022
CompletedStudy Start
First participant enrolled
October 15, 2022
CompletedFirst Posted
Study publicly available on registry
October 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2023
CompletedFebruary 8, 2023
February 1, 2023
11 months
October 5, 2022
February 6, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Change from baseline Diabetes Distress Scale at 3 months post intervention
Diabetes distress will be measured by the Chinese 15-item Diabetes Distress Scale (CDDS-15). It consists of 15 items. rated on a six-point Likert scale from 1 = 'not a problem' to 6 = 'a serious problem'. A mean item score of 2-2.9 and ≥3.0 indicates moderate and severe distress, respectively.
Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)
Change from baseline HbA1c at 3 months post-intervention
Blood glucose level of participants will be evaluated with an HbA1c level, which measures the average blood glucose level during the past three months. An HbA1c level over 7% is considered suboptimal glycaemic control, indicating a high risk of diabetes complications.2 HbA1c values obtained every 3-4 months will be collected from the patient electronic information system.
Baseline (T0), and 3-month post-intervention (T2)
Secondary Outcomes (3)
Diabetes self-management behaviours
Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)
Diabetes management self-efficacy
Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)
Psychological flexibility
Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)
Study Arms (2)
Acceptance and commitment therapy integrated in diabetes education (ACT-DE)
EXPERIMENTALThe proposed intervention is a six-week acceptance-based diabetes education programme (ACT-DE) comprising acceptance and commitment therapy and diabetes education. Session 1: Diabetes education and introduction of ACT-DE programme Session 2: Mindfulness cultivation Session 3: Value clarification Session 4: Integrating ACT into diabetes self-management Session 5: Booster session Session length: 120 minutes Group-based (6-8 participants) and face-to-face mode of delivery
Diabetes education
PLACEBO COMPARATOROne session of diabetes education, group-based (6-8 participants) and 120 minutes via face-to-face delivery.
Interventions
Acceptance and Commitment Therapy is a third-wave psychological therapy to cultivate participants' acceptance attitude to diabetes and motivate them for a value-driven persistent diabetes self-management, directed by six psychological processes in the ACT hexagonal model, including acceptance, cognitive defusion, the present moment, self-as-context, value clarification and committed action.
Eligibility Criteria
You may qualify if:
- community-dwelling adults Hong Kong Chinese residents,
- aged 18-64,
- diagnosed with type 2 diabetes for over one year;
- at least moderate level of diabetes distress as measured with the Chinese
- Diabetes Distress Scale (CDDS-15; mean score \>2 per item);
- having suboptimal blood glucose control as shown by HbA1c level of ≥ 7% in the laboratory results within the past six months;
- able to communicate in Cantonese and give written consent
You may not qualify if:
- history of a clinically diagnosed mental illness such as depression and anxiety disorder, and/or an acute/severe medical disease;
- noticeable cognitive impairment(s) as indicated by the total score (\<6 of 10) of the Abbreviated Mental Test;
- recently received/receiving any psychological therapy such as mindfulness or acceptance-based therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Nethersole School of Nursing
Hong Kong, Hong Kong Island, Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor who is responsible for collecting outcome data and data entry has no idea about the group allocation or participants.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
October 5, 2022
First Posted
October 18, 2022
Study Start
October 15, 2022
Primary Completion
August 31, 2023
Study Completion
November 30, 2023
Last Updated
February 8, 2023
Record last verified: 2023-02